Stroke prevention in atrial fibrillation
- PMID: 27560276
- DOI: 10.1016/S0140-6736(16)31257-0
Stroke prevention in atrial fibrillation
Abstract
Atrial fibrillation is found in a third of all ischaemic strokes, even more after post-stroke atrial fibrillation monitoring. Data from stroke registries show that both unknown and untreated or under treated atrial fibrillation is responsible for most of these strokes, which are often fatal or debilitating. Most could be prevented if efforts were directed towards detection of atrial fibrillation before stroke occurs, through screening or case finding, and treatment of all patients with atrial fibrillation at increased risk of stroke with well-controlled vitamin K antagonists or non-vitamin K antagonist anticoagulants. The default strategy should be to offer anticoagulant thromboprophylaxis to all patients with atrial fibrillation unless defined as truly low risk by simple validated risk scores, such as CHA2DS2-VASc. Assessment of bleeding risk using the HAS-BLED score should focus attention on reversible bleeding risk factors. Finally, patients need support from physicians and various other sources to start anticoagulant treatment and to ensure adherence to and persistence with treatment in the long term.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Comment in
-
Atrial fibrillation and stroke: unrecognised and undertreated.Lancet. 2016 Aug 20;388(10046):731. doi: 10.1016/S0140-6736(16)31412-X. Lancet. 2016. PMID: 27560257 No abstract available.
Similar articles
-
Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.Int J Stroke. 2016 Jul;11(5):565-74. doi: 10.1177/1747493016632239. Epub 2016 Feb 29. Int J Stroke. 2016. PMID: 26927811
-
Clinical Stroke prevention in atrial fibrillation.J R Coll Physicians Edinb. 2017 Mar;47(1):13-23. doi: 10.4997/JRCPE.2017.105. J R Coll Physicians Edinb. 2017. PMID: 28569277 Review.
-
Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.Expert Rev Cardiovasc Ther. 2013 Dec;11(12):1619-29. doi: 10.1586/14779072.2013.839214. Expert Rev Cardiovasc Ther. 2013. PMID: 24215192 Review.
-
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18. J Am Coll Cardiol. 2013. PMID: 24055744
-
Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Adv Ther. 2012. PMID: 22684583 Review.
Cited by
-
Management of cerebral amyloid angiopathy and atrial fibrillation: We are still far from precision medicine.World J Cardiol. 2024 May 26;16(5):231-239. doi: 10.4330/wjc.v16.i5.231. World J Cardiol. 2024. PMID: 38817646 Free PMC article. Review.
-
Racial and Ethnic Disparities in Initiation of Direct Oral Anticoagulants Among Medicare Beneficiaries.JAMA Netw Open. 2024 May 1;7(5):e249465. doi: 10.1001/jamanetworkopen.2024.9465. JAMA Netw Open. 2024. PMID: 38709533 Free PMC article.
-
Atrial Fibrillation and Early Vascular Aging: Clinical Implications, Methodology Issues and Open Questions-A Review from the VascAgeNet COST Action.J Clin Med. 2024 Feb 20;13(5):1207. doi: 10.3390/jcm13051207. J Clin Med. 2024. PMID: 38592046 Free PMC article. Review.
-
Screening for Atrial Fibrillation by Digital Health Technology in Older People in Homecare Settings: A Feasibility Trial.Int J Telemed Appl. 2024 Mar 25;2024:4080415. doi: 10.1155/2024/4080415. eCollection 2024. Int J Telemed Appl. 2024. PMID: 38567031 Free PMC article.
-
The Impact of Atherosclerotic Burden on Vascular Outcomes in Patients with Stroke and Atrial Fibrillation: The ATHENA study.Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241240746. doi: 10.1177/10760296241240746. Clin Appl Thromb Hemost. 2024. PMID: 38562096 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical